Business Context and Reporting Period
Company: InTest Corporation (INTT)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2025
Business Overview: InTest is a global supplier of test and process technology solutions for semiconductor, auto/EV, defense/aerospace, industrial, life sciences, and safety/security markets. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.
Key Financial Metrics
| Metric (in thousands) | Q2 2025 | Q2 2024 | 6M 2025 | 6M 2024 |
|---|---|---|---|---|
| Revenue | $28,130 | $33,991 | $54,767 | $63,815 |
| Gross Profit | $11,973 | $13,797 | $23,029 | $26,873 |
| Gross Margin | 42.6% | 40.6% | 42.0% | 42.1% |
| Operating Income (Loss) | $(927) | $336 | $(3,808) | $828 |
| Net Income (Loss) | $(503) | $230 | $(2,832) | $892 |
| Diluted EPS | $(0.04) | $0.02 | $(0.23) | $0.07 |
| Cash from Operations (6M) | $4,847 (2025) vs $(3,015) (2024) | |||
| Cash & Equivalents (End of Period) | $19,248 | |||
| Total Debt (Current + Long-term) | $10,093 |
Material Changes vs. Prior Period
- Revenue Decline: Q2 2025 revenue decreased 17.2% year-over-year (YoY) to $28.1 million, driven primarily by declines in the Auto/EV (-45.4%), Life Sciences (-36.8%), and Semi (-0.7% sequentially, though flat YoY) markets. The six-month revenue decline was 14.2%.
- Profitability Shift: The company reported a net loss of $0.5 million for Q2 2025 compared to a net income of $0.2 million in Q2 2024. Operating loss widened to $0.9 million due to revenue contraction and restructuring costs.
- Restructuring Costs: The company incurred $0.2 million in restructuring costs in Q2 2025 ($0.5 million for the six months), primarily related to the consolidation of Videology operations from the Netherlands to Massachusetts and a leadership transition in the Environmental Technologies segment. No such costs were incurred in the prior year period.
- Orders and Backlog: While revenue declined, total orders for Q2 2025 increased 6.0% YoY to $27.8 million, driven by strength in Auto/EV and Life Sciences. However, backlog decreased to $37.9 million at June 30, 2025, from $47.7 million in the prior year.
- Cash Flow Improvement: Net cash provided by operating activities for the six months ended June 30, 2025, was $4.8 million, a significant improvement of $7.9 million compared to the prior year, largely due to improved collections of accounts receivable.
Guidance, Outlook, Risks, and Unusual Items
- Debt Covenant Waiver: As of June 30, 2025, the company was out of compliance with its fixed charge coverage ratio covenant (0.80 vs. required 1.25). On August 5, 2025, InTest executed a Sixth Amendment to its Loan Agreement with M&T Bank, waiving this covenant through March 31, 2026. During this period, the company must pledge cash collateral equal to its open debt ($5.9 million) and obtain consent to utilize the revolving facility.
- Supply Chain Risks: The company faces ongoing risks related to a sole-source capacitor supplier in Israel due to regional conflict and a sole-source supplier in Belarus for Acculogic parts due to sanctions. While safety stock and new suppliers have been identified, there is uncertainty regarding future availability and costs.
- Market Volatility: Management notes continued cyclicality in the semiconductor market and economic uncertainty in global trade, including potential tariff impacts. Approximately 50% of sales are shipped outside the U.S.
- Acquisition Integration: The company continues to integrate Alfamation (acquired March 2024), which contributed to increased amortization of intangible assets ($1.7 million for six months 2025 vs. $1.5 million in 2024).
Investor Verification Checklist
- Covenant Compliance: Verify the terms of the August 5, 2025, debt amendment and the impact of the cash collateral pledge on liquidity flexibility.
- Supply Chain Resilience: Assess the status of the OFAC and Global Affairs Canada license applications for the Belarus supplier and the sufficiency of safety stock for the Israel-based capacitor supplier.
- Restructuring Execution: Monitor the completion of the Videology consolidation and the realization of expected cost savings by the end of 2025.
- Order Conversion: Track the conversion of the increased Q2 orders (up 6% YoY) into revenue in subsequent quarters, given the decline in backlog.
- Segment Performance: Analyze the divergence between the declining Semi market revenue and the growing orders in Auto/EV and Life Sciences to validate the diversification strategy.